Longevity & AgingResearch PaperPaywall

Metabolic Molecules Drive Cellular Aging Through DNA Damage and Autophagy Pathway

Scientists discover how aging cells rewire metabolism to promote senescence through DRAM1-mediated autophagy mechanisms.

Saturday, April 18, 2026 0 views
Published in Autophagy
Microscopic view of aging cells with accumulated metabolic molecules shown as glowing particles, DNA damage visible as broken strands

Summary

Researchers identified how aging cells accumulate specific metabolic molecules that promote cellular senescence through DNA damage and autophagy. The study found that N-acetylhistamine and phosphatidylethanolamine build up in aging human stem cells and mouse liver tissue, triggering a pathway called DRAM1-mediated pro-senescent autophagy (DMPA). This process involves the protein DRAM1 activating cellular cleanup mechanisms that paradoxically accelerate aging rather than preventing it. The findings suggest that targeting these metabolic pathways could potentially delay cellular senescence and aging.

Detailed Summary

This research reveals a critical mechanism by which aging cells become trapped in a cycle of accelerated senescence through metabolic dysfunction. Scientists studied human umbilical cord stem cells and mouse liver tissue to understand how DNA damage during aging affects cellular cleanup processes called autophagy.

The team discovered that aging cells accumulate two key metabolic molecules: N-acetylhistamine (N-AcHA) and phosphatidylethanolamine (PE). These compounds trigger increased production of DRAM1, a protein that normally helps cells respond to DNA damage by activating autophagy. However, in aging cells, this creates a harmful feedback loop called DRAM1-mediated pro-senescent autophagy (DMPA).

Experiments showed that adding N-AcHA to young mouse liver cells was sufficient to increase DNA damage and senescence, while PE supplementation enhanced autophagy without causing DNA damage. The combination of both molecules triggered the full DMPA response in stem cells, demonstrating how metabolic changes drive cellular aging.

Interestingly, this aging-associated autophagy differs from normal cellular cleanup processes. Unlike typical autophagy that removes damaged proteins, DMPA maintains certain protein aggregates that may support continued cellular dysfunction. The research suggests that targeting these specific metabolic pathways could offer new approaches to delay cellular senescence and potentially extend healthspan by breaking the cycle of metabolic dysfunction that accelerates aging.

Key Findings

  • Aging cells accumulate N-acetylhistamine and phosphatidylethanolamine metabolites
  • DRAM1 protein creates pro-senescent autophagy pathway that accelerates aging
  • N-acetylhistamine supplements alone can trigger DNA damage in young cells
  • Combined metabolic treatments activate full senescence program in stem cells
  • DMPA differs from normal autophagy by maintaining protein aggregates

Methodology

Researchers used human umbilical cord mesenchymal stem cells and mouse liver tissue models, analyzing metabolic changes during aging and testing effects of specific metabolite supplementation on DNA damage and senescence markers.

Study Limitations

Study limited to cell culture and mouse models; human clinical relevance unclear. Only abstract available limits full assessment of methodology and statistical significance of findings.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.